Yanming Deng
Neck And Thoracic Oncology
Foshan, China
Foshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
First case report of ensartinib in a patient with metastatic ALK rearranged lung cancer with ALK I1171N mutation: a case report.
Journal: World journal of surgical oncology
Published: August 02, 2022
Case Report: Durable partial response to icotinib plus crizotinib in a lung adenocarcinoma patient with double uncommon EGFR G719D/L861Q mutations and an acquired novel CUX1-MET fusion.
Journal: Frontiers in oncology
Published: April 02, 2022
Biochemistry and transcriptome analyses reveal key genes and pathways involved in high-aluminum stress response and tolerance in hydrangea sepals.
Journal: Plant physiology and biochemistry : PPB
Published: February 18, 2022
miR-663b promotes tumor cell proliferation, migration and invasion in nasopharyngeal carcinoma through targeting TUSC2.
Journal: Experimental and therapeutic medicine
Published: November 01, 2021
A 12-hour rapid titration method for cancer pain: a randomized, controlled, open-label study.
Journal: Annals of palliative medicine
Published: August 31, 2020
Efficacy and safety of apatinib as third- or further-line therapy for patients with advanced NSCLC: a retrospective study.
Journal: Therapeutic advances in medical oncology
Published: May 29, 2020
Fosaprepitant versus aprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: a multicenter, randomized, double-blind, double-simulated, positive-controlled phase III trial.
Journal: Annals of translational medicine
Published: April 21, 2020
A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group.
Journal: Leukemia
Published: August 19, 2019
miR-663b promotes tumor cell proliferation, migration and invasion in nasopharyngeal carcinoma through targeting TUSC2.
Journal: Experimental and therapeutic medicine
Published: February 10, 2017
Novel biomarkers of nasopharyngeal carcinoma metastasis risk identified by reverse phase protein array based tumor profiling with consideration of plasma Epstein-Barr virus DNA load.
Journal: Proteomics. Clinical applications
Published: June 22, 2016
[Retracted] miR‑663 promotes NPC cell proliferation by directly targeting CDKN2A.
Journal: Molecular medicine reports
Published: June 04, 2016
miR-663 promotes NPC cell proliferation by directly targeting CDKN2A.
Journal: Molecular medicine reports
Published: June 04, 2016
Last Updated: 09/26/2026